Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 3
1955 2
1956 2
1957 4
1958 3
1959 1
1960 5
1961 3
1962 13
1963 11
1964 14
1965 17
1966 26
1967 34
1968 19
1969 20
1970 33
1971 28
1972 24
1973 23
1974 27
1975 37
1976 34
1977 35
1978 31
1979 51
1980 57
1981 70
1982 109
1983 84
1984 110
1985 131
1986 144
1987 129
1988 166
1989 146
1990 147
1991 166
1992 216
1993 192
1994 214
1995 227
1996 249
1997 296
1998 304
1999 310
2000 309
2001 342
2002 340
2003 386
2004 404
2005 372
2006 341
2007 369
2008 389
2009 404
2010 442
2011 481
2012 500
2013 516
2014 486
2015 522
2016 574
2017 625
2018 611
2019 624
2020 645
2021 730
2022 665
2023 498
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

14,282 results

Results by year

Filters applied: . Clear all
Page 1
Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
Tanaka H, Hagiwara S, Shirane D, Yamakawa T, Sato Y, Matsumoto C, Ishizaki K, Hishinuma M, Chida K, Sasaki K, Yonemochi E, Ueda K, Higashi K, Moribe K, Tadokoro T, Maenaka K, Taneichi S, Nakai Y, Tange K, Sakurai Y, Akita H. Tanaka H, et al. ACS Nano. 2023 Feb 14;17(3):2588-2601. doi: 10.1021/acsnano.2c10501. Epub 2023 Jan 31. ACS Nano. 2023. PMID: 36719091
Phase separation of an actin nucleator by junctional microtubules regulates epithelial function.
Tsukita K, Kitamata M, Kashihara H, Yano T, Fujiwara I, Day TF, Katsuno T, Kim J, Takenaga F, Tanaka H, Park S, Miyata M, Watanabe H, Kondoh G, Takahashi R, Tamura A, Tsukita S. Tsukita K, et al. Among authors: tanaka h. Sci Adv. 2023 Feb 15;9(7):eadf6358. doi: 10.1126/sciadv.adf6358. Epub 2023 Feb 15. Sci Adv. 2023. PMID: 36791197 Free PMC article.
Diagnostic significance of secondary bacteremia in patients with COVID-19.
Nakagawara K, Kamata H, Chubachi S, Namkoong H, Tanaka H, Lee H, Otake S, Fukushima T, Kusumoto T, Morita A, Azekawa S, Watase M, Asakura T, Masaki K, Ishii M, Endo A, Koike R, Ishikura H, Takata T, Matsushita Y, Harada N, Kokutou H, Yoshiyama T, Kataoka K, Mutoh Y, Miyawaki M, Ueda S, Ono H, Ono T, Shoko T, Muranaka H, Kawamura K, Mori N, Mochimaru T, Fukui M, Chihara Y, Nagasaki Y, Okamoto M, Amishima M, Odani T, Tani M, Nishi K, Shirai Y, Edahiro R, Ando A, Hashimoto N, Ogura S, Kitagawa Y, Kita T, Kagaya T, Kimura Y, Miyazawa N, Tsuchida T, Fujitani S, Murakami K, Sano H, Sato Y, Tanino Y, Otsuki R, Mashimo S, Kuramochi M, Hosoda Y, Hasegawa Y, Ueda T, Takaku Y, Ishiguro T, Fujiwara A, Kuwahara N, Kitamura H, Hagiwara E, Nakamori Y, Saito F, Kono Y, Abe S, Ishii T, Ohba T, Kusaka Y, Watanabe H, Masuda M, Watanabe H, Kimizuka Y, Kawana A, Kasamatsu Y, Hashimoto S, Okada Y, Takano T, Katayama K, Ai M, Kumanogoh A, Sato T, Tokunaga K, Imoto S, Kitagawa Y, Kimura A, Miyano S, Hasegawa N, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Nakagawara K, et al. Among authors: tanaka h. J Infect Chemother. 2023 Apr;29(4):422-426. doi: 10.1016/j.jiac.2023.01.006. Epub 2023 Jan 20. J Infect Chemother. 2023. PMID: 36682606 Free PMC article.
Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force.
Lee H, Chubachi S, Namkoong H, Asakura T, Tanaka H, Otake S, Nakagawara K, Morita A, Fukushima T, Watase M, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Lee H, et al. Among authors: tanaka h. BMC Infect Dis. 2022 Dec 12;22(1):935. doi: 10.1186/s12879-022-07927-w. BMC Infect Dis. 2022. PMID: 36510172 Free PMC article.
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity.
Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, Morita T, Kato Y, Liu YC, Motooka D, Naito Y, Takuwa A, Sugihara F, Tanaka K, Wing JB, Sonehara K, Tomofuji Y; Japan COVID-19 Task Force; Namkoong H, Tanaka H, Lee H, Fukunaga K, Hirata H, Takeda Y, Okuzaki D, Kumanogoh A, Okada Y. Edahiro R, et al. Among authors: tanaka h. Nat Genet. 2023 May;55(5):753-767. doi: 10.1038/s41588-023-01375-1. Epub 2023 Apr 24. Nat Genet. 2023. PMID: 37095364 Free PMC article.
UV-laser-diode-pumped visible Tb3+:LiLuF4 lasers.
Badtke M, Kalusniak S, Tanaka H, Kränkel C. Badtke M, et al. Among authors: tanaka h. Opt Lett. 2023 Jul 1;48(13):3379-3382. doi: 10.1364/OL.494164. Opt Lett. 2023. PMID: 37390135
Chemical synthesis of sialoglyco-architectures.
Ando H, Komura N, Tanaka HN, Imamura A, Ishida H. Ando H, et al. Among authors: tanaka hn. Adv Carbohydr Chem Biochem. 2022;81:31-56. doi: 10.1016/bs.accb.2022.09.003. Epub 2022 Oct 12. Adv Carbohydr Chem Biochem. 2022. PMID: 36435533
Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
Ushida T, Katayama Y, Hiasa Y, Nishihara M, Tajima F, Katoh S, Tanaka H, Maeda T, Furusawa K, Richardson M, Kakehi Y, Kikumori K, Kuroha M. Ushida T, et al. Among authors: tanaka h. Neurology. 2023 Mar 14;100(11):e1193-e1206. doi: 10.1212/WNL.0000000000201709. Epub 2022 Dec 14. Neurology. 2023. PMID: 36517235 Free PMC article. Clinical Trial.
A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy.
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: tanaka h. Lung Cancer. 2023 Mar;177:44-50. doi: 10.1016/j.lungcan.2023.01.011. Epub 2023 Jan 28. Lung Cancer. 2023. PMID: 36731290 Free article. Clinical Trial.
14,282 results
You have reached the last available page of results. Please see the User Guide for more information.